Managerial Database II
Acquired Immunodeficiency Syndrome
|Study Design:||Observational Model: Cohort
Time Perspective: Cross-Sectional
|Official Title:||Network-Wide Assessment of Current Health Status and Behavioral Risk Factors: An Expanded Study for New Sites in ATN III|
- Collect information on for adolescents and young adults with HIV infection engaged in care at the AMTUs [ Time Frame: 1 year ]Collect information on rates of adherence to medical regimens, sexual risk behavior, substance use and mental health concerns, along with basic demographic and biomedical data for adolescents and young adults with HIV infection engaged in care at the AMTUs to better understand the extent of risk behaviors as well as to understand risk and protective factors in this population.
- To better understand the complex relationships between adherence to medical regimens, sexual risk behavior, substance use and mental health concerns, and basic demographic and biomedical data in adolescents and young adults with HIV infection. [ Time Frame: 1 year ]
|Study Start Date:||April 2011|
|Study Completion Date:||June 2012|
|Primary Completion Date:||June 2012 (Final data collection date for primary outcome measure)|
All HIV-infected adolescents and young adults engaged in care at sites newly participating in ATN III and their affiliates who are between 12 and 24 years of age, inclusive, are aware of their HIV status and understand written and/or verbal English will be eligible for inclusion in the study. In addition, new patients who have their initial clinic visit within the enrollment period will also be eligible for participation.
The proposed study is a cross sectional study intended to be conducted at each of the Adolescent Medicine Trials Units (AMTUs) newly participating in ATN III and to enroll all participating patients followed at each site. This approach will allow for the examination of the broad spectrum of youth participating in the ATN, including those newly entered into care.
Psychosocial and risk-taking behavioral data will be collected using Audio Computer-Assisted Self-Interview (ACASI) for English-speaking participants, or a paper-and-pencil Spanish-language survey with identical measures to the ACASI for Spanish-speaking participants; biomedical information will be collected through medical chart abstraction.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01322217
|United States, Colorado|
|University of Colorado Denver|
|Aurora, Colorado, United States, 80045|
|United States, Maryland|
|Johns Hopkins University|
|Baltimore, Maryland, United States, 21287|
|United States, Massachusetts|
|The Fenway Institute-Fenway Health|
|Boston, Massachusetts, United States, 02115|
|United States, Michigan|
|Wayne State University-Children's Hospital of Michigan|
|Detroit, Michigan, United States, 48201|
|United States, Texas|
|Baylor College of Medicine - Pediatrics Allergy and Immunology|
|Houston, Texas, United States, 77030|
|Study Chair:||Heather Huszti, PhD||Adolescent Trials Network|